BioSig Subsidiary ViralClear Submits Investigational New Drug Application to the FDA for Phase II Clinical Trials for Merimepodib, an Orally Administered Treatment for Patients with COVID-19
Westport, CT, April 24, 2020 (GLOBE NEWSWIRE) —In vitro studies demonstrated decrease of viral production by over 98%Upon approval, clinical […]